IDiyas

For the Inventor, By the Inventor

Cliftonville, United Kingdom

Malcolm Morville

USPTO Granted Patents = 8

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Cliftonville, GB (1979 - 1980)
  • Margate, GB (1980)

Company Filing History:

goldMedal8 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1979-1980

Loading Chart...
8 patents (USPTO):Explore Patents
1. 4239779 - Use of phenylglyoxylic acids and derivatives thereof in the treatment of (1980-12-16),
2. 4219566 - Phenylglyoxylic acids and derivatives thereof (1980-08-26),
3. 4186210 - Method of treatment with glycinamides (1980-01-29),
4. 4185117 - Method of treatment with glycinamides (1980-01-22),
5. 4185116 - L- and DL- Phenylglycines to treat diseases or conditions attributable (1980-01-22),
6. 4179521 - L- and DL-Phenylglycines to treat diseases or conditions attributable to (1979-12-18),
7. 4179520 - L- and DL-Phenylglycines to treat a disease or condition attributable to (1979-12-18),
8. 4148920 - Therapeutic L- and DL- phenylglycines to treat diseases or disorders of (1979-04-10),

Title: The Innovative Contributions of Malcolm Morville

Introduction

Malcolm Morville, an accomplished inventor based in Cliftonville, GB, has made significant strides in the field of pharmaceutical innovations. With a portfolio boasting 8 patents, Morville's work has had a profound impact, particularly in the treatment of various medical conditions.

Latest Patents

Among his latest innovations, two noteworthy patents focus on the use of phenylglyoxylic acids and their derivatives. These patents are specifically aimed at the treatment of ischemic heart disease and the management of hyperglycemia in diabetes patients. His research on these compounds highlights their potential therapeutic benefits, showcasing Morville's dedication to advancing medical science.

Career Highlights

Malcolm Morville has built his career at Pfizer Corporation, a leading global pharmaceutical company known for its commitment to research and development. Throughout his tenure, he has contributed to groundbreaking discoveries that have positioned Pfizer at the forefront of medical innovation.

Collaborations

In his pursuit of excellence, Morville has collaborated with notable colleagues such as Ian T Barnish and Peter E Cross. These partnerships have fostered a collaborative environment that encourages innovative thinking and the sharing of ideas, ultimately leading to significant advancements in their research.

Conclusion

In summary, Malcolm Morville stands out as a pivotal figure in pharmaceutical innovation. His contributions, particularly in the realm of phenylglyoxylic acids, demonstrate his commitment to improving patient outcomes through scientific research and collaborative efforts. As the medical field continues to evolve, the impact of his work will undoubtedly resonate for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…